Estudio sobre neuroblastoma: Dephosphorylation of the Proneural Transcription Factor ASCL1 Re-Engages a Latent Post-Mitotic Differentiation Program in Neuroblastoma. https://t.co/J2JuGX8dqm https://t.co/EPIEvqRuJj #investigacionUFV #repositorioDDFV
RT @CRUKCamPaeds: Prof Anna Philpott and her team are studying the developmental origins of neuroblastoma 2020 - https://t.co/LfW7Rf7EiH 2…
RT @CRUKCamPaeds: Prof Anna Philpott and her team are studying the developmental origins of neuroblastoma 2020 - https://t.co/LfW7Rf7EiH 2…
RT @CRUKCamPaeds: Prof Anna Philpott and her team are studying the developmental origins of neuroblastoma 2020 - https://t.co/LfW7Rf7EiH 2…
RT @CRUKCamPaeds: Prof Anna Philpott and her team are studying the developmental origins of neuroblastoma 2020 - https://t.co/LfW7Rf7EiH 2…
RT @CRUKCamPaeds: Prof Anna Philpott and her team are studying the developmental origins of neuroblastoma 2020 - https://t.co/LfW7Rf7EiH 2…
RT @CRUKCamPaeds: Prof Anna Philpott and her team are studying the developmental origins of neuroblastoma 2020 - https://t.co/LfW7Rf7EiH 2…
Prof Anna Philpott and her team are studying the developmental origins of neuroblastoma 2020 - https://t.co/LfW7Rf7EiH 2020 @SIOPEurope - https://t.co/gMDkAfewju They were recently part of @CR_UK launch of Star Awards https://t.co/7uEpC0Sj5A #Internatio
Preventing phosphorylation of #TranscriptionFactor ASCL1 in #Neuroblastoma cells drives mitotic exit and neuronal differentiation and may be a new approach to development of differentiation therapies, according to Ali et al. https://t.co/p2LB9GO7XE https:
Preventing phosphorylation of #TranscriptionFactor ASCL1 in #Neuroblastoma cells drives mitotic exit and neuronal differentiation and may be a new approach to development of differentiation therapies, Ali et al report. https://t.co/fSRfRuHz5Y https://t.co
New Rapid Impact article: Preventing phosphorylation of #TranscriptionFactor ASCL1 in #Neuroblastoma cells drives mitotic exit and neuronal differentiation and may be a new approach to development of differentiation therapies, according to Ali et al. htt